An interventional study of SYNERGY stent and BVS ABSORB scaffold in Coronary Artery Disease, sponsored by University of Malaya. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-05-04.
Sponsored by University of Malaya · Not applicable, Interventional, and Treatment
This is a prospective, non-randomized, single center clinical trial to assess neointimal coverage on the stent or scaffold strut and apposition of SYNERGY™ and ABSORB in minimum of 12 eligible human subject at 4 month and 12 month after stent or scaffold implantation using OCT and CAS
All of the subject will received SYNERGY™ stent in one of the blocked coronary artery and ABSORB scaffold strut in the other artery. All subjects must have 2 coronary arteries stenosis of more than 70%.
5,596 studies on the registry are indexed under Coronary Artery Disease; 955 are open to participants now.
This study's enrollment of 13 is below the median of 123 across 3,435 interventional studies indexed under Coronary Artery Disease.
Browse Coronary Artery Disease studies →University of Malaya is the lead sponsor of 280 studies on the registry; 55 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
One of the blocked coronary artery of a patient will received SYNERGY stent
Device: SYNERGY stent
Another blocked coronary artery of the same patient will received ABSORB scaffold
Device: BVS ABSORB scaffold
Apposition and neointimal coverage on the stent and scaffold strut
Neointimal coverage on the stent and scaffold strut and their apposition using OCT and CAS at 4 month after the stent implantation.
Time frame: 4 months
Apposition and neointimal coverage on the stent and scaffold strut
Neointimal coverage on the stent or scaffold and their apposition using OCT and CAS at 12 month after stent implantation
Time frame: 12 months
No study locations are listed for this record.
This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Malaya